Citations 2
Results of E1496: A phase III trial of CVP with or without maintenance rituximab in advanced indolent lymphoma (NHL)
Hochster, H. S., Weller, Edie, Gascoyne, Randy D. , Frankel, SR, Horning, SJ, Ryan, Thomas M. , Habermann, Thomas M.
Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 6502-6502
Prognostic significance of the follicular lymphoma international prognostic index (FLIPI) in the E1496 trial of chemotherapy with or without maintenance rituximab
Colocci, Natalia, Weller, Edie, Hochster, H. S., Gascoyne, Randall D., Kumm, B., Frankel, SR, Horning, SJ, Ryan, T., Habermann, Thomas M.
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 6526-6526